The popularity of copyright’s blockbuster initially sparked a boom for major pharmaceutical companies, however recent shifts present a uncertain scenario for investors. Generic alternatives are eroding earnings, and https://abelncob589633.dailyblogzz.com/41666319/the-blue-pill-and-the-pharmaceutical-industry-a-risky-investment